Clinical Trial Update: Effect of Cabergoline on Weight and Glucose Tolerance [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on cabergoline for weight and glucose tolerance in obese individuals, covering Phase 1 and Phase 2, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Obesity

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Columbia University | Conditions: Body Weight, Impaired Glucose Tolerance in Obese | Phase 1, Phase 2 | Status: COMPLETED